Moonlake Immunotherapeutics · NASDAQ:MLTX

Santos da Silva Jorge sold 47,775 Moonlake Immunotherapeutics shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Santos da Silva Jorge (Director, Chief Executive Officer) sold 47,775 Moonlake Immunotherapeutics shares at US$20.03 for US$957K under a trading plan, leaving 2,877,118 shares. Filed Jul 2, 2026 (Form 4).

Sold
47,775 shares
Price
US$20.03
Value
US$957K
Holding after
2,877,118 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Class A ordinary shares, par value $0.0001 per shareSale47,775US$20.032,877,118Direct

Source

View original at SEC

Related